Eight (10%) of the patients displayed moderately strong (IRS value ≥6) SSTR expression in their HCC samples (SSTR1, 1 patient; SSTR2, 2 patients; SSTR3, 2 patients; SSTR5, 3 patients; no overlapping staining). This evidence concerns the gene SSTR2 and hepatocellular carcinoma.